The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
pharmacia & upjohn company | 355 |
pfizer products | 90 |
sugen | 29 |
zoetis p&u | 28 |
biorexis pharmaceutical corporation | 18 |
elan pharmaceuticals | 16 |
pfizer health | 14 |
zoetis services | 14 |
pfizer | 10 |
pah usa 15 | 7 |
pharmacia & upjohn company | 7 |
sugen | 3 |
pfizer health | 1 |
pharmacia corporation | 1 |
pah p&u | 1 |
zoetis p&u | 1 |
zoetis services | 1 |
pfizer products | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
anti-ctla-4 antibody compositions | 35 | 2005 |
pyridine[3,4-b]pyrazinones | 33 | 2006 |
cellular permissivity factor for viruses, and uses thereof | 30 | 2004 |
attenuated pasteurellaceae bacterium having a mutation in a virulence gene | 26 | 1999 |
pyrrole substituted 2-indolinone protein kinase inhibitors | 24 | 2000 |
exendin fusion proteins | 20 | 2006 |
crystals including a malic acid salt of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-2-oxo-3h-… 🛈 | 19 | 2001 |
pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as pde5 inhibitors | 18 | 2005 |
anti-bacterial vaccine compositions | 18 | 1999 |
anti-ige vaccines | 17 | 2000 |